Literature DB >> 22608878

Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study.

Mary Leahy1, Meinir Krishnasamy, Alan Herschtal, Mathias Bressel, Tracey Dryden, Keen Hun Tai, Farshad Foroudi.   

Abstract

PURPOSE OF THE RESEARCH: As the number of men living with prostate cancer is increasing worldwide, the requirement for follow up care also grows. This study was undertaken to evaluate nurse-led, telephone follow up, for men with low to intermediate risk prostate cancer treated with radical radiotherapy when compared with medical follow up. METHODS AND SAMPLE: A non-randomized, two-cohort, comparative study. 169 men diagnosed with prostate cancer were recruited from outpatient clinics at a tertiary cancer centre in Australia. 83 men were recruited to cohort 1 (control) (51 low to intermediate risk; 32 high risk) and 86 to cohort 2 (intervention) (51 low to intermediate risk; 35 high risk). High risk patients, regardless of cohort, received medical follow up. Low to intermediate risk patients in cohort 2 were triaged to nurse-led review for their six month review appointment. Nurse-led follow up consisted of six monthly telephone consultations and PSA testing. MEASURES: Participants completed the Satisfaction with Consultation Scale, the Brief Distress Thermometer and the Expanded Prostate Cancer Index Composite. KEY
RESULTS: There was no statistically significant difference in patient satisfaction on any of the study measures between the nurse-led and standard medical follow up at six months following treatment completion. However, where there was a trend towards significance (p=0.051), it favoured the nurse-led follow up regimen.
CONCLUSIONS: Nurse-led telephone consultation provides an acceptable model of follow-up for men diagnosed with low to intermediate risk prostate cancer. Multi-centre randomised controlled trials are needed to support the efficacy of nurse-led, telephone follow up services. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22608878     DOI: 10.1016/j.ejon.2012.04.003

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  16 in total

1.  Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer.

Authors:  Satoshi Yokoyama; Satoko Yajima; Chihiro Sakai; Shuji Yamashita; Yoshihiro Noguchi; Yoko Ino; Kazuhiro Iguchi; Hitomi Teramachi
Journal:  Can Pharm J (Ott)       Date:  2017-09-22

2.  How calls from carers, friends and family members of someone affected by cancer differ from those made by people diagnosed with cancer; analysis of 4 years of South Australian Cancer Council Helpline data.

Authors:  Kate M Fennell; L Heckel; C Wilson; M Byrnes; P M Livingston
Journal:  Support Care Cancer       Date:  2016-01-04       Impact factor: 3.603

Review 3.  Nurse-led follow-up care for cancer patients: what is known and what is needed.

Authors:  Jacqueline de Leeuw; Maria Larsson
Journal:  Support Care Cancer       Date:  2013-07-05       Impact factor: 3.603

4.  Indian nurses' beliefs on physical activity promotion practices for cancer survivors in a tertiary care hospital-a cross-sectional survey.

Authors:  Hritika D Pai; Stephen Rajan Samuel; K Vijaya Kumar; Namrata S Chauhan; Charu Eapen; Alicia Olsen; Justin W L Keogh
Journal:  PeerJ       Date:  2022-05-23       Impact factor: 3.061

5.  Telepsychiatry as an Economically Better Model for Reaching the Unreached: A Retrospective Report from South India.

Authors:  Sydney Moirangthem; Sabina Rao; Channaveerachari Naveen Kumar; Manjunatha Narayana; Neelaveni Raviprakash; Suresh Bada Math
Journal:  Indian J Psychol Med       Date:  2017 May-Jun

6.  Development and evaluation of evidence-informed clinical nursing protocols for remote assessment, triage and support of cancer treatment-induced symptoms.

Authors:  Dawn Stacey; Gail Macartney; Meg Carley; Margaret B Harrison
Journal:  Nurs Res Pract       Date:  2013-02-18

7.  Human chorionic gonadotropin β induces migration and invasion via activating ERK1/2 and MMP-2 in human prostate cancer DU145 cells.

Authors:  Zongwen Li; Chunliu Li; Lianlian Du; Yan Zhou; Wei Wu
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

8.  Thyroid cancer survivors' perceptions of survivorship care follow-up options: a cross-sectional, mixed-methods survey.

Authors:  Jacqueline L Bender; David Wiljer; Anna M Sawka; Richard Tsang; Nour Alkazaz; James D Brierley
Journal:  Support Care Cancer       Date:  2015-11-03       Impact factor: 3.359

9.  Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial.

Authors:  Julia Wade; Peter N Holding; Susan Bonnington; Leila Rooshenas; J Athene Lane; C Elizabeth Salter; Kate Tilling; Mark J Speakman; Simon F Brewster; Simon Evans; David E Neal; Freddie C Hamdy; Jenny L Donovan
Journal:  BMJ Open       Date:  2015-09-18       Impact factor: 2.692

10.  Current nutrition promotion, beliefs and barriers among cancer nurses in Australia and New Zealand.

Authors:  Petra G Puhringer; Alicia Olsen; Mike Climstein; Sally Sargeant; Lynnette M Jones; Justin W L Keogh
Journal:  PeerJ       Date:  2015-11-10       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.